Literature DB >> 6461994

Effect of diabetogenic nitrosourea on the activity of the pentose phosphate hunt in isolated islets.

J O Akpan, P H Wright, W E Dulin.   

Abstract

The effect of streptozotocin (STZ) on the activity of the pentose phosphate shunt in islets was studied. Isolated rat islets were pre-incubated with glucose (1.7 mM) alone or with streptozotocin (STZ) or N-methyl-N-nitrosourea (MNU). The effects of these pretreatments on glucose metabolism and insulin secretion were assessed during subsequent incubation with either (1.14C), (6.14C). or (U.14C). glucose (16.7 mM) alone or plus phenazine methosulfate (PMS). Islets pretreated with STZ (1.5 mM) metabolized less (1.14C) and (U.14C). glucose. The order of inhibition by STZ of (14C)-glucose metabolism by islets was: (1.14C). greater than (U.14C). greater than (6.14C)-glucose. Whereas PMS (0.5 mM) increased the metabolism of both (U.14C). and (1.14C)-glucose, the metabolism of (6.14C)-glucose by STZ-pretreated islets was not increased by PMS. In a separate series of experiments, the total NADP+ + NADPH, but not the NAD content of the islets decreased after 2 min exposure of islets of STZ. At 30-min exposure, the levels of both pyridine coenzymes and that of 6-phosphogluconate were significantly decreased. The level of NADP+ + NADPH in islets was decreased more than the level of NAD. Insulin secretion was suppressed by the nitrosoureas. PMS (0.5 mM) increased the level of NADP+ + NADPH content of islets and augmented insulin secretion. It is concluded that the pentose phosphate pathway is inhibited on brief exposure of islets to STZ or MNU. Such inhibition may contribute to the suppression of insulin secretion caused by these nitrosoureas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461994     DOI: 10.1007/bf02581184

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  29 in total

1.  Effects of streptozotocin in vitro on proinsulin biosynthesis, insulin release and ATP content of isolated rat islets of Langerhans.

Authors:  A Maldonato; P A Trueheart; A E Renold; G W Sharp
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

Review 2.  Insulin secretion: multifactorial regulation for a single process of release. The Minkowski award lecture delivered on September 7, 1972 before the European Association for the study of Diabetes at Madrid, Spain.

Authors:  W J Malaisse
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

3.  Studies of the diabetogenic action of streptozotocin.

Authors:  A Junod; A E Lambert; L Orci; R Pictet; A E Gonet; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1967-10

4.  Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15,774.

Authors:  J S Evans; G C Gerritsen; K M Mann; S P Owen
Journal:  Cancer Chemother Rep       Date:  1965-10

5.  The structure of streptozotocin.

Authors:  R R Herr; J K Jahnke; A D Argoudelis
Journal:  J Am Chem Soc       Date:  1967-08-30       Impact factor: 15.419

6.  Diabetogenic effects of n-nitrosomethylurea in the chinese hamster.

Authors:  E Wilander; R Gunnarsson
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-03

7.  Enzymes of glucose metabolism in normal mouse pancreatic islets.

Authors:  S J Ashcroft; P J Randle
Journal:  Biochem J       Date:  1970-08       Impact factor: 3.857

8.  Insulin immunoassay by back-titration using alcohol precipitation of insulin-antibody complexes.

Authors:  D R Makulu; D Vichick; P H Wright; K E Sussman; P L Yu
Journal:  Diabetes       Date:  1969-10       Impact factor: 9.461

9.  Insulin secretion from toadfish islet tissue stimulated by pyridine nucleotides.

Authors:  D Watkins; S J Cooperstein; P K Dixit; A Lazarow
Journal:  Science       Date:  1968-10-11       Impact factor: 47.728

10.  Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.

Authors:  T Anderson; P S Schein; M G McMenamin; D A Cooney
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

View more
  6 in total

1.  Reduction in blood and urine glucose levels in streptozotocin and alloxan diabetes by phenazine methosulfate.

Authors:  J O Akpan
Journal:  Acta Diabetol Lat       Date:  1989 Jul-Sep

2.  Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.

Authors:  Sachin A Gupte
Journal:  Drug Dev Res       Date:  2010-05-01       Impact factor: 4.360

3.  Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.

Authors:  Rakhee S Gupte; Beverly C Floyd; Mark Kozicky; Shimran George; Zoltan I Ungvari; Vanessa Neito; Michael S Wolin; Sachin A Gupte
Journal:  Free Radic Biol Med       Date:  2009-02-20       Impact factor: 7.376

4.  Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.

Authors:  Sabrina Serpillon; Beverly C Floyd; Rakhee S Gupte; Shimran George; Mark Kozicky; Venessa Neito; Fabio Recchia; William Stanley; Michael S Wolin; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

5.  The characterization of phenazine methosulfate stimulated insulin secretion.

Authors:  J O Akpan; P H Wright; W E Dulin
Journal:  Acta Diabetol Lat       Date:  1987 Jan-Mar

6.  Streptozotocin is not toxic to the human fetal B cell.

Authors:  B E Tuch; J R Turtle; C J Simeonovic
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.